CNTA vs EXPE · $6.15B cap vs P/E 20, rev $7.74B
Centessa Pharmaceuticals PLC ADR (CNTA) versus Expedia Group Inc. (EXPE) — a side-by-side from cached financials, not a winner call.
Centessa Pharmaceuticals PLC ADR (CNTA) is a biotechnology company listed on US.
Expedia Group Inc. (EXPE) is a travel services company listed on US.
Latest reported CNTA revenue for 2024-12-31 was $0. Net income was -$235.8M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. CNTA currently screens at market cap $6.15B.
Latest reported EXPE revenue for 2026-06-30 was $7.74B. Net income was $872.0M. EXPE currently screens at market cap $21.71B and trailing P/E 20.4.
CNTA currently screens at market cap $6.15B. EXPE currently screens at market cap $21.71B and trailing P/E 20.4.
Not investment advice. Open the CNTA and EXPE stock pages for the full models.
Not investment advice.